T1	Treatment 0 19	Dofequidar fumarate
T2	Treatment 49 96	cyclophosphamide, doxorubicin, and fluorouracil
T3	Treatment 206 283	dofequidar plus cyclophosphamide, doxorubicin, and fluorouracil (CAF) therapy
T4	Treatment 303 312	CAF alone
T5	Treatment 517 535	placebo-controlled
T6	Treatment 584 596	CAF therapy:
T7	Treatment 600 773	days/cycle, with doxorubicin (25 mg/m2) and fluorouracil (500 mg/m2) administered on days 1 and 8 and cyclophosphamide (100 mg orally [PO]) administered on day 1 through 14.
T8	Treatment 792 814	dofequidar (900 mg PO)
T9	Treatment 846 858	doxorubicin.
T10	Treatment 1006 1009	CAF
T11	Treatment 1034 1050	dofequidar + CAF
T12	Treatment 1624 1634	dofequidar
T13	Treatment 1702 1718	Dofequidar + CAF
